Department of Neurosurgery, National Hospital Organization Disaster Medical Center, 3256, Midori-cho, 190-0014, Tachikawa-shi, Tokyo, Japan.
Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, 2-8-29, Musashi-dai, 183-8524, Fuchu-shi, Tokyo, Japan.
Clin Neuroradiol. 2020 Sep;30(3):481-487. doi: 10.1007/s00062-019-00810-3. Epub 2019 Jul 23.
The efficacy of mechanical thrombectomy in the treatment of occlusions of the second segment of the middle cerebral artery (M2) has not been firmly established.
This study analyzed data from patients who had undergone mechanical thrombectomy for the first segment of the middle cerebral artery (M1) and M2 occlusion from the Tama-REgistry of Acute endovascular Thrombectomy (TREAT) between January 2015 and March 2017, which is a multicenter database in the Tama area of Tokyo, Japan. The M1 and M2 occlusions were compared in order to evaluate the safety and efficacy of M2 thrombectomy.
A total of 515 patients were registered, whereby 160 patients with M1 occlusion and 51 patients with M2 occlusion were included. While the puncture-to-reperfusion time was longer in the M2 occlusions (median 43 min, range 30-61 min vs. median 60 min, range 38-79 min, p = 0.01), no significant differences were seen in the proportion of patients with successful reperfusion, postoperative hemorrhagic complications and good outcome (modified Rankin scale ≤2 at 90 days). Younger age was the only independent factor associated with good outcome in patients with M2 occlusions as determined by the multivariate analysis (p = 0.033, odds ratio 0.91, 95% confidence interval 0.83-0.99).
The outcome and the safety profile of mechanical thrombectomy for M2 occlusions are favorable and comparable to those of the M1 occlusion thrombectomy.
机械取栓治疗大脑中动脉第二段(M2)闭塞的疗效尚未得到明确证实。
本研究分析了 2015 年 1 月至 2017 年 3 月期间在日本东京多摩地区的多中心数据库——急性血管内血栓切除术塔玛登记(TREAT)中接受大脑中动脉第一段(M1)和 M2 闭塞机械取栓治疗的患者数据。对 M1 和 M2 闭塞进行了比较,以评估 M2 取栓的安全性和疗效。
共登记了 515 例患者,其中 M1 闭塞 160 例,M2 闭塞 51 例。M2 闭塞组的穿刺至再通时间较长(中位数 43 分钟,范围 30-61 分钟比中位数 60 分钟,范围 38-79 分钟,p=0.01),但成功再通率、术后出血性并发症和良好预后(90 天时改良 Rankin 量表≤2)的比例无显著差异。多变量分析显示,年龄较小是 M2 闭塞患者预后良好的唯一独立因素(p=0.033,优势比 0.91,95%置信区间 0.83-0.99)。
M2 闭塞机械取栓的结果和安全性与 M1 闭塞取栓相当,且预后良好。